A Study to Investigate the Effects of Durvalumab With Oleclumab Following Chemoradiation in Participants With Locally Advanced Unresectable Non-Small Cell Lung Cancer (LADOGA)
Clinical trial NCT06606847 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06606847
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-24
- Primary completion
- 2026-05-04
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.